Inhibitory Effects of Successive Solvant Extracts of Barleria gibsoni Dalz. on the Proliferation of MDA MB 4355 (Human Breast Cancer) and Hep G2 (Liver Cancer Cell line)

 

Firoj A. Tamboli*, Harinath N. More

Department of Pharmacognosy, Bharati Vidyapeeth College of Pharmacy, Near Chitranagari, Kolhapur -416013

*Corresponding Author E-mail: firojtamboli143@gmail.com, firoj.tamboli@bharatividyapeeth.edu

 

ABSTRACT:

The objective of this study was to investigate the ant proliferative activity of the successive solvent extract of leaves of plant of Barleria gibsoni Dalz. against MDA MB 4355 (Human breast cancer) and Hep G2 (Liver cancer cell line). 5 fluorouracil was given as reference drug. The leaves of plant were dried in shade and they were powdered and extracted with different solvents extract like petroleum ether, chloroform, acetone, ethyl acetate, ethanol. The preliminary phytochemical tests were done. Pet ether, chloroform extract of leaves showed that significant ant proliferative effects were obtained against MDA MB 4355 (Human breast cancer) by SRB assay method and ethanol extract of leaves showed moderate activity against Hep G2 (Liver cancer cell line) by MTT assay method due to presence of phytoconstituents present in the plant.

 

KEY WORDS: Barleria gibsoni Dalz. ant proliferative activity, 5-fluorouracil, MDA MB 4355 (Human breast cancer) and Hep G2 (Liver cancer cell line).

 

 


INTRODUCTION:

Barleria gibsoni Dalz. (Acanthaceae) is widely distributed throughout Africa, India, Sri Lanka and tropical Asia. It is commonly known as Neel Koranti, the juice of the leaf is used in cataract, ulcer and fever. The dried bark is used in cough treatment and the leaves chewed to relieve toothache. The paste of the root is applied to disperse boils and glandular swellings1. It exhibits several medicinal properties. Leaves are also used by some tribal communities for the treatment of piles and to control irritation. Plant is also used in stiffness of limbs, enlargement of scrotum and sciatica2-5. In recent years multiple drug resistance has developed due to indiscriminate use of existing antimicrobial drugs in the treatment of infectious diseases 6.

 

MATERIAL AND METHOD:

Plant Material:

The fresh leaves of the Barleria gibsoni were collected during the month of May-June when flowering, from Satara region, Maharashtra, India. The plant was authenticated by Botanical survey of India, Pune, Maharashtra, India.  A voucher specimen (BSI/WRC/Tech/2013/FAT 01 dated 27th December, 2013) has been deposited at the herbarium of same place for further reference.

 

Preparation of Extracts:

The leaves of Barleria gibsoni were washed with water, air- dried at room temperature and then reduced to coarse powder. A powdered leaves (100g) was successively extracted with petroleum ether, chloroform, acetone, ethyl acetate and ethanol using Soxhlet apparatus. The extracts were filtered and the filtrates were concentrated under reduced pressure to obtain the extracts as solid residues.

 


Table.1: Phytochemical screening of Barleria gibsoni Dalz.

Secondary Metabolites

Petroleum ether

Chloroform

Acetone

Ethyl acetate

Ethanol

Alkaloids

+

-

+

-

+

Flavonoids

-

+

+

+

+

Steroids

-

-

_

-

+

Saponins

-

-

+

+

+

 


Phytochemical test:

Preliminary phytochemical analysis of the extract was performed by simple chemical tests.7,8

 

Cancer Cell Cultures:

Hep G2, (liver cancer cell line) MDA MB 4355 (Human breast cancer) cell lines were purchased from NCCS, Pune, India. All cell lines were grown and maintained in suitable (RPMI-15-media and were grown and subculture in medium supplemented with 10% fetal bovine serum, 1% L-Glutamine.1% penicillin- streptomycin-amphotericine-B antibiotic solution. All cells were trypsinated using try sin-EDTA solution and seeded in96 well plates.

 

Ant proliferative assay of extract on MDA MB 4355 (Human breast cancer) 9,10:-

The MDA MB 4355 (Human breast cancer) was maintained in L-15-media supplemented with 10 % fetal bovine serum. The cells were plated at a density of 1 × 105 cells per well in a 96-well plate, and cultured  for  24  h  at  37 °C.  The cells were subsequently exposed to 10, 50 µg/ml. The plates were incubated for 24 h, Test compounds were prepared in PBS and Controls were performed with medium alone. Ant proliferative activity was assessed by performing the Sulphorhodamine B (SRB) assay. Cells were fixed by adding 25 µL of ice-cold 50% trichloroacetic acid on top of the growth medium and the plates were incubated at 4 °C for 1 h, after which plates were washed to remove traces of medium, drug and serum. SRB stain (50 µL; 0.4% in 1% acetic acid) (Sigma) was added to each well and left in contact with the cells for 30 min after which they were washed with 1% acetic acid, rinsing 4 times until only dye adhering to the cells was left. The plates were then dried and 100 µL of 10 mM Tris buffer (Sigma) added to each well to solubilise the dye. The plates were shaken gently for 5 min and absorbance was read at 550 nm using a micro plate reader. Lastly percent cytotoxicity of the compounds was calculated by using following formula.

 

Percent Cytotoxicity =

Reading of control - Reading of treated cells X100

                        Reading of control

 

Antiproliferative assay of extract on Hep G2 (Liver cancer cell line) 11,12

The  Hep G2 cell  line  was  maintained  in  MEM  medium  supplemented with  10  %  fetal bovine serum. The cells were plated at a density of 1 × 105 cells per well in a 96-well plate, and cultured for 24 h at 37°C.  The cells were subsequently exposed to 10, 50 µg/ml. The  plates  were  incubated  for  48 h,  and  cell  proliferation  was measured  by  adding  10  µL  of  MTT (thiazolyl blue tetrazolium  bromide)  dye  (5  mg ml-1 in phosphate-buffered saline) per well. The plates were incubated for a further 4 h at 37°C in a humidified chamber containing 5% CO2. Formazan crystals formed due to reduction of dye by viable cells in each well were dissolved in 200 µl DMSO, and absorbance was read at 490 nm. The results were compared with the standard drug inhibitors 5- flurouracil. (20µg/ml) percent inhibition was calculated as above formula.

 

RESULTS:

The preliminary Phytochemical analysis revealed the presence of alkaloids, flavonoids saponins and steroids

 

Table . 2: Antiproliferative activity of Successive solvent Extracts of Barleria gibsoni Dalz. against MDA MB 4355 (Human breast cancer) by SRB assay

Successive solvent

Extracts of leaves

% Inhibition

(10 µg/ml)

% Inhibition

(50 µg/ml)

Pet ether

61.66

61.66

Chloroform

60.00

63.33

Acetone

< 50

31.66

Ethyl acetate

45.00

40.00

Ethanol

23.33

26.66

5- flurouracil (50 µg/ml)

55.00

 64.33

 

As shown in Table. 2 the successive solvent extract displayed inhibition activities against breast human cancer cell lines. Notably, petroleum ether and chloroform extracts exhibited significant inhibitory activities against MDA MB 4355 cell lines compared to the positive control 5- fluorouracil. Remaining extracts showed moderate inhibitory activities against MDA MB 4355 cell lines.

 

Table . 3: Antiproliferative activity of Successive solvent Extracts of Barleria gibsoni Dalz. against Hep G2 cell line (Human liver cancer) by MTT assay

 Successive solvent

 Extracts of leaves

% Inhibition

(10 µg/ml)

% Inhibition

(50 µg/ml)

Petroleum ether

21.07

21.53

Chloroform

>100

>100

Acetone

49.70

>100

Ethyl acetate

30.72

23.96

Ethanol

25.14

60.86

5- flurouracil (50 µg/ml)

 64.33

80.43

As shown in Table.3, the successive solvent extract displayed inhibition activities against liver human cancer cell lines. Notably, ethanol extract of leaves exhibited moderate inhibitory activities against Hep G2 cell lines compared to the positive control 5- fluorouracil.

 

DISCUSSION:

From the present study it can be said that ethanol extract of leaves of Barleria gibsoni has antiproliferative activity against Hep G2 cell line by MTT assay method and pet ether and chloroform extract of leaves of Barleria gibsoni has antiproliferative activity against MDA MB 4355 breast cancer cell line by SRB assay method due to presence of phytoconstituents present in the plant. It is need to explore the isolation, characterization and development of drug which could be help to hopeful treatment in cancer disease.

 

REFERENCES:

1.     Gupta R, Pramod K, Dixit V., Dobhal M. Antifertility studies of the root extract of the Barleria prionitis Linn in male albino rats with special reference to testicular cell population dynamics. Journal of ethnopharmacol. 70; 2000: 111–117.

2.     Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi:   CSIR; pp 33–34, 1956.

3.      Ambasta SP. The useful plants of India. New Delhi: CSIR; 1986.

4.     Bhalla NP, Sahu TR, Mishra GP, Dakwala RN. J Econ Taxon Bot. 3: 23, 1992.

5.     Jain SK, Defillips RA. Medicinal plants of India. New Delhi: CSIR, 1991.

6.     Service RF. Antibiotics that resist resistance. Science, 270; 1992: 724-727.

7.     Harbone,J.P., Phytochemical methods, a guide to modern technique of plant analysis (chapmann and hall, London),.1-271; 1973

8.     Mukaherjee PK, Quality control of herbal drugs (an approach to evaluation of botanicals),Business Horizon’s, New Delhi pp. 380-421; 2002.

9.     Potchanapond Graidist, Mananya Martla  and Yaowapa Sukpondma, Cytotoxic Activity of Piper cubeba Extract in Breast Cancer Cell Lines, Nutrients 7; 2015: 2707-2718.

10.  Filip Grbovic, Milan S.Stankovic, Milena Curcic, Natasa Dordevic, Dragana Seklic, Marina Topuzovic and Snezana Markovic, In Vitro Cytotoxic Activity of Origanum vulgare L. on HCT-116 and MDA-MB-231 Cell Lines, Plants 2;2013: 371-378

11.  Ray S, Murmu N, Adhikari J, Bhattacharyya S, Adhikari S, Banerjee S., Inhibition of Hep G2 hepatic cancer cell growth and CCl induced liver cytotoxicity in Swiss albino mice by Mahua extract. J Environ Pathol Toxicol Oncol. 33(4); 2014: 295-314.

12.  Ali M. Mahmoud and Hany A. EL-shemy, Cytotoxic Profiling of Some Compounds of Natural Origin against HepG2 Liver Cancer Cell Line in-vitro. Journal of Arid Land Studies, 22-1; 2012: 191 -194.

 

 

 

 

 

Received on 02.12.2015          Accepted on 20.12.2015        

© Asian Pharma Press All Right Reserved

Asian J. Pharm. Res. 5(4): October- December, 2015; Page 183-185

DOI: 10.5958/2231-5691.2015.00028.3